SOAR Corporation

SOAR Corporation provides drug and alcohol treatment from its location at 9150 Marshall Street Suite 18 in Philadelphia, Pennsylvania. It is a private provider.

Levels of care offered here include intensive outpatient (IOP), standard outpatient counseling, medication-assisted treatment (MAT), a federally certified opioid treatment program, co-occurring (dual diagnosis) mental health treatment, and telehealth therapy. Clinicians use approaches such as anger management, cognitive behavioral therapy, contingency management/motivational incentives, motivational interviewing, and Matrix Model. For opioid use disorder, the program uses methadone and buprenorphine.

Payment options include Medicare, Medicaid, private health insurance, and state-financed health insurance plan other than Medicaid. Coverage depends on your specific plan, so verify benefits before admission.

The program accepts young adults, adults, and seniors. It offers specialized groups for young adults, pregnant/postpartum women, seniors or older adults, and clients with co-occurring mental and substance use disorders. Services are available in Spanish.

SOAR Corporation is accredited by Commission on Accreditation of Rehabilitation Facilities (CARF) and licensed or certified by the state substance use treatment agency, state department of health, and SAMHSA certification for opioid treatment program (OTP).

Support services include aftercare/continuing care, discharge planning, naloxone and overdose education, and outcome follow-up after discharge.